Predict How Any Patient Will Respond To Any Therapy
Next-generation AI simulates drug-patient outcomes so every clinical development decision is backed by evidence.
Discuss the EvidenceProud to Work with
Simulate Clinical Realities Before They Happen, Grounded in Human Nuance and Therapeutic Effect
Reality vs Simulation
Powered by
Omni-Channel Data
An integrated data framework bridging the biomedical, clinical, and epidemiological domains
350M
Lives of multimodal data
100K
Drug data elements in our Biomedical Knowledge Graph
180K+
Trials with curated results data
Use Cases
Supporting Sponsors from Early Clinical Development to Approval
Clinical Development
- Protocol Optimization
- Indication Selection
- TPP
- PTS
- Market Forecasting
- Enrollment Prediction
Business Development
- Search and Evaluation - Many to Few
- Comparative Deep Dive - Few to One
- Asset Diligence & Valuation
- Asset Out-licensing & Disposition
Portfolio Management
- Portfolio Prioritization
- Inter-portfolio Synergy and Competition
- Portfolio Gaps and Opportunities
Optimizing Clinical Outcomes With
Enrollment and Market in Mind
Protocol Optimization
Optimize your clinical trial protocol with critical inputs that allow you to refine key criteria, such as:
-
Highly nuanced inclusion and exclusion criteria
-
Investigational arm – regimen, combination, dosage, arm size
-
Any control arm – SoC, placebo, competitor
-
Outcomes and endpoints
Outcome Predictions
Make data-driven and more effective clinical trial design decisions based on in-depth virtual trial results that mirror the depth and precision of actual trial data.
Enrollment Prediction
Predict recruitment curves by combining protocol cohort definitions with site-level data, enabling researchers to compare expected enrollment rates across cohorts.
Market Forecasting
Make more informed, strategic decisions with patient counts predicted across geographical markets and compared across cohorts, based on a specific cohort definition.
Demonstrating Value Across Therapeutic Areas
Case Studies by Disease Type
MASH
Head & Neck Cancer